Age at cancer onset in germline TP53 mutation carriers: Association with polymorphisms in predicted G-quadruplex structures

Carcinogenesis

Volumn 35, Issue 4, 2014, Pages 807-815

  Sagne, Charlotte ^a,b   Marcel, Virginie ^a,b,o   Bota, Maria ^c   Martel Planche, Ghyslaine ^d   Nobrega, Amanda ^e,f   Palmero, Edenir Inêz ^g   Perriaud, Laury ^a,b   Boniol, Mathieu ^c   Vagner, Stephan ^b,h   Cox, David G ⁱ   Chan, Chang S ^j   Mergny, Jean Louis ^k,l   Olivier, Magali ^d   Ashton Prolla, Patricia ^m,n   Hall, Janet ^a,b   Hainaut, Pierre ^c,p   Achatz, Maria Isabel ^e,f  

^a INSERM U612   (France)

^b INSTITUT CURIE   (France)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e A C CAMARGO CANCER CENTER   (Brazil)

^f National Institute of Science and Technology in Oncogenomics   (Brazil)

^g BARRETOS CANCER HOSPITAL   (Brazil)

^h CNRS UMR3348   (France)

ⁱ CENTRE LÉON BÉRARD   (France)

^j ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^k INSTITUT EUROPÉEN DE CHIMIE ET BIOLOGIE   (France)

^l UNIVERSITÉ DE BORDEAUX   (France)

^m HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

ⁿ National Institute for Populational Medical Genetics   (Brazil)

^o UNIVERSITÉ LYON 1   (France)

^p UNIV GRENOBLE ALPES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; MESSENGER RNA; PROTEIN P53;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; BRAZIL; CANCER DIAGNOSIS; CANCER FAMILY; CODON; CONTROLLED STUDY; DNA STRUCTURE; EARLY CANCER; FAMILIAL CANCER; GENE DUPLICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; GERMLINE MUTATION; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; BASE SEQUENCE; DNA; G-QUADRUPLEXES; GENES, P53; HETEROZYGOTE DETECTION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 84898667137     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt381     Document Type: Article

References (44)

1. Li, F.P. et al. (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res., 48, 5358-5362.
2. Mai, W.J. et al. (2012) Characterization of the tilapia p53 gene and its role in chemical-induced apoptosis. Biotechnol. Lett., 34, 1797-1805.
3. Birch, J.M. et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res., 54, 1298-1304.
4. Eeles, R.A. (1995) Germline mutations in the TP53 gene. Cancer Surv., 25, 101-124.
5. Chompret, A. (2002) The Li-Fraumeni syndrome. Biochimie, 84, 75-82.
6. Malkin, D. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
7. Srivastava, S. et al. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747-749.
8. Varley, J.M. et al. (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res., 57, 3245-3252.
9. Ruijs, M.W. et al. (2010) TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J. Med. Genet., 47, 421-428.
10. Tinat, J. et al. (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J. Clin. Oncol., 27, e108-9; author reply e110.
11. Bougeard, G. et al.; French LFS working group. (2008) Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J. Med. Genet., 45, 535-538.
12. Villani, A. et al. (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol., 12, 559-567.
13. Bond, G.L. et al. (2004) A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell, 119, 591-602.
14. Bougeard, G. et al. (2006) Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome. J. Med. Genet., 43, 531-533.
15. Marcel, V. et al. (2009) TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. J. Med. Genet., 46, 766-772.
16. Ruijs, M.W. et al. (2007) The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes. Eur. J. Hum. Genet., 15, 110-114.
17. Wu, C.C. et al. (2011) Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum. Genet., 129, 663-673.
18. Knappskog, S. et al. (2011) Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk. Transcription, 2, 207-210.
19. Achatz, M.I. et al. (2007) The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Cancer Lett., 245, 96-102.
20. Bochman, M.L. et al. (2012) DNA secondary structures: stability and function of G-quadruplex structures. Nat. Rev. Genet., 13, 770-780.
21. Ribeyre, C. et al. (2009) The yeast Pif1 helicase prevents genomic instability caused by G-quadruplex-forming CEB1 sequences in vivo. PLoS Genet., 5, e1000475.
22. Paeschke, K. et al. (2011) DNA replication through G-quadruplex motifs is promoted by the Saccharomyces cerevisiae Pif1 DNA helicase. Cell, 145, 678-691.
23. Paeschke, K. et al. (2013) Pif1 family helicases suppress genome instability at G-quadruplex motifs. Nature, 497, 458-462.
24. Cayrou, C. et al. (2012) New insights into replication origin characteristics in metazoans. Cell Cycle, 11, 658-667.
25. Millevoi, S. et al. (2012) G-quadruplexes in RNA biology. Wiley Interdiscip. Rev. RNA, 3, 495-507.
26. Halder, R. et al. (2012) Bisquinolinium compounds induce quadruplexspecific transcriptome changes in HeLa S3 cell lines. BMC Res. Notes, 5, 138.
27. Gomez, D. et al. (2004) Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res., 32, 371-379.
28. Marcel, V. et al. (2011) G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. Carcinogenesis, 32, 271-278.
29. Ghosh, A. et al. (2004) Regulation of human p53 activity and cell localization by alternative splicing. Mol. Cell. Biol., 24, 7987-7997.
30. Courtois, S. et al. (2002) DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene, 21, 6722-6728.
31. Yin, Y. et al. (2002) p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol., 4, 462-467.
32. Marcel, V. et al. (2011) Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ., 18, 1815-1824.
33. Decorsière, A. et al. (2011) Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3'-end processing and function during DNA damage. Genes Dev., 25, 220-225.
34. Petitjean, A. et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat., 28, 622-629.
35. Garritano, S. et al. (2010) Detailed haplotype analysis at the TP53 locus in p. R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Hum. Mutat., 31, 143-150.
36. Kikin, O. et al. (2006) QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res., 34(Web Server issue), W676-W682.
37. Scaria, V. et al. (2006) Quadfinder: server for identification and analysis of quadruplex-forming motifs in nucleotide sequences. Nucleic Acids Res., 34(Web Server issue), W683-W685.
38. Huppert, J.L. et al. (2005) Prevalence of quadruplexes in the human genome. Nucleic Acids Res., 33, 2908-2916.
39. Stacey, S.N. et al.; Swedish Low-risk Colorectal Cancer Study Group. (2011) A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat. Genet., 43, 1098-1103.
40. Nakken, S. et al. (2009) The disruptive positions in human G-quadruplex motifs are less polymorphic and more conserved than their neutral counterparts. Nucleic Acids Res., 37, 5749-5756.
41. Baral, A. et al. (2012) Quadruplex-single nucleotide polymorphisms (Quad-SNP) influence gene expression difference among individuals. Nucleic Acids Res., 40, 3800-3811.
42. Ribeiro, R.C. et al. (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl Acad. Sci. USA, 98, 9330-9335.
43. Maier, B. et al. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev., 18, 306-319.
44. Davidson, W.R. et al. (2010) Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos. BMC Dev. Biol., 10, 102.